The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
As of close of business last night, Ocugen Inc’s stock clocked out at $0.81, up 5.22% from its previous closing price of $0.77. In other words, the price has increased by $5.22 from its previous closing price. On the day, 6.5 million shares were traded. OCGN stock price reached its highest trading level at $0.8484 during the session, while it also had its lowest trading level at $0.733.
Ratios:
To gain a deeper understanding of OCGN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.60 and its Current Ratio is at 2.60. In the meantime, Its Debt-to-Equity ratio is 2.00 whereas as Long-Term Debt/Eq ratio is at 1.95.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on October 15, 2024, initiated with a Buy rating and assigned the stock a target price of $4.
On March 01, 2023, Chardan Capital Markets Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $3.50.
On August 23, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.Mizuho initiated its Buy rating on August 23, 2022, with a $5 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 26 ’24 when Fernandes Prabhavathi bought 10,000 shares for $0.91 per share. The transaction valued at 9,095 led to the insider holds 10,000 shares of the business.
Castillo Kirsten bought 25,000 shares of OCGN for $22,848 on Nov 22 ’24. The Director now owns 75,000 shares after completing the transaction at $0.91 per share. On Aug 16 ’24, another insider, RAMESH KUMAR, who serves as the Director of the company, bought 116,705 shares for $1.25 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OCGN now has a Market Capitalization of 236545120 and an Enterprise Value of 230568352. For the stock, the TTM Price-to-Sale (P/S) ratio is 52.33 while its Price-to-Book (P/B) ratio in mrq is 14.87. Its current Enterprise Value per Revenue stands at 50.988 whereas that against EBITDA is -4.243.
Stock Price History:
The Beta on a monthly basis for OCGN is 4.14, which has changed by -0.5290698 over the last 52 weeks, in comparison to a change of 0.11936104 over the same period for the S&P500. Over the past 52 weeks, OCGN has reached a high of $1.98, while it has fallen to a 52-week low of $0.51. The 50-Day Moving Average of the stock is 19.71%, while the 200-Day Moving Average is calculated to be -6.82%.
Shares Statistics:
It appears that OCGN traded 3.77M shares on average per day over the past three months and 4013150 shares per day over the past ten days. A total of 292.03M shares are outstanding, with a floating share count of 286.77M. Insiders hold about 1.80% of the company’s shares, while institutions hold 26.38% stake in the company. Shares short for OCGN as of 1745971200 were 68225493 with a Short Ratio of 18.10, compared to 1743379200 on 65794489. Therefore, it implies a Short% of Shares Outstanding of 68225493 and a Short% of Float of 23.76.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
A detailed examination of Ocugen Inc (OCGN) is currently in progress, with 3.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.05 and low estimates of -$0.07.
Analysts are recommending an EPS of between -$0.21 and -$0.25 for the fiscal current year, implying an average EPS of -$0.23. EPS for the following year is -$0.25, with 2.0 analysts recommending between -$0.22 and -$0.27.
Revenue Estimates
A total of 4 analysts have provided revenue estimates for OCGN’s current fiscal year. The highest revenue estimate was $5.6M, while the lowest revenue estimate was $1.48M, resulting in an average revenue estimate of $2.52M. In the same quarter a year ago, actual revenue was $4.05M
